171 related articles for article (PubMed ID: 10084584)
1. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration.
Caron P; Chauvin S; Christin-Maitre S; Bennet A; Lahlou N; Counis R; Bouchard P; Kottler ML
J Clin Endocrinol Metab; 1999 Mar; 84(3):990-6. PubMed ID: 10084584
[TBL] [Abstract][Full Text] [Related]
2. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.
Kottler ML; Chauvin S; Lahlou N; Harris CE; Johnston CJ; Lagarde JP; Bouchard P; Farid NR; Counis R
J Clin Endocrinol Metab; 2000 Sep; 85(9):3002-8. PubMed ID: 10999776
[TBL] [Abstract][Full Text] [Related]
3. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations.
Seminara SB; Beranova M; Oliveira LM; Martin KA; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2000 Feb; 85(2):556-62. PubMed ID: 10690855
[TBL] [Abstract][Full Text] [Related]
4. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone.
Meysing AU; Kanasaki H; Bedecarrats GY; Acierno JS; Conn PM; Martin KA; Seminara SB; Hall JE; Crowley WF; Kaiser UB
J Clin Endocrinol Metab; 2004 Jul; 89(7):3189-98. PubMed ID: 15240592
[TBL] [Abstract][Full Text] [Related]
5. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred.
de Roux N; Young J; Brailly-Tabard S; Misrahi M; Milgrom E; Schaison G
J Clin Endocrinol Metab; 1999 Feb; 84(2):567-72. PubMed ID: 10022417
[TBL] [Abstract][Full Text] [Related]
6. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
[TBL] [Abstract][Full Text] [Related]
7. Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene.
Caron P; Imbeaud S; Bennet A; Plantavid M; Camerino G; Rochiccioli P
J Clin Endocrinol Metab; 1999 Oct; 84(10):3563-9. PubMed ID: 10522996
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the GnRH receptor gene: a new cause of autosomal-recessive hypogonadotropic hypogonadism.
Kottler ML; Counis R; Bouchard P
Arch Med Res; 1999; 30(6):481-5. PubMed ID: 10714361
[TBL] [Abstract][Full Text] [Related]
9. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.
Habiby RL; Boepple P; Nachtigall L; Sluss PM; Crowley WF; Jameson JL
J Clin Invest; 1996 Aug; 98(4):1055-62. PubMed ID: 8770879
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro.
Kaiser UB; Jakubowiak A; Steinberger A; Chin WW
Endocrinology; 1997 Mar; 138(3):1224-31. PubMed ID: 9048630
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
Partsch CJ; Hermanussen M; Sippell WG
J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
[TBL] [Abstract][Full Text] [Related]
12. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females.
Seminara SB; Achermann JC; Genel M; Jameson JL; Crowley WF
J Clin Endocrinol Metab; 1999 Dec; 84(12):4501-9. PubMed ID: 10599709
[TBL] [Abstract][Full Text] [Related]
13. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect.
Barkan AL; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1985 Dec; 61(6):1118-25. PubMed ID: 3932448
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
Apter D; Bützow TL; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
[TBL] [Abstract][Full Text] [Related]
16. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor.
Pralong FP; Gomez F; Castillo E; Cotecchia S; Abuin L; Aubert ML; Portmann L; Gaillard RC
J Clin Endocrinol Metab; 1999 Oct; 84(10):3811-6. PubMed ID: 10523035
[TBL] [Abstract][Full Text] [Related]
17. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
18. Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: human GnRHR "knockout".
Silveira LF; Stewart PM; Thomas M; Clark DA; Bouloux PM; MacColl GS
J Clin Endocrinol Metab; 2002 Jun; 87(6):2973-7. PubMed ID: 12050282
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.
Aloi JA; Bergendahl M; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547
[TBL] [Abstract][Full Text] [Related]
20. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
